# Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment

> **NCT00133276** · PHASE2,PHASE3 · COMPLETED · sponsor: **Foundation for Liver Research** · enrollment: 80 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Escitalopram
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00133276
- **Lead sponsor:** Foundation for Liver Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2008-06
- **Final completion:** 2009-12
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2010-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00133276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00133276, "Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00133276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*